Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
CDNA

Market Cap: $2.6B

CI

CareDx, Inc

CDNA

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin70.58%

EBITDA Margin3.40%

EBIT Margin-0.92%

Pre-tax Margin25.15%

Net Profit Margin24.23%

Earnings Yield4.29%

Valuation Multiples

Price / Book6.08

Price / Sales5.68

Price / Earnings23.36

PEG-0.02

Forward PEG2.26

EV / Sales4.90

EV / EBITDA144.35

EV / Operating Cash Flow23.98

EV / Free Cash Flow26.41

Price / Free Cash Flow30.57

Price / Operating Cash Flow27.62

Cash Flow & Capital

Free Cash Flow / Share$1.65

Operating Cash Flow / Share$1.82

Free Cash Flow Yield3.27%

Capex / Revenue1.88%

Capex / Operating Cash Flow9.20%

Capex / Depreciation0.44

Stock Compensation / Revenue8.07%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio4.58

Quick Ratio4.51

Cash Ratio3.99

Debt / Assets0.04

Debt / Capital0.04

Debt / Equity0.05

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-22.78

Solvency Ratio1.22

Financial Leverage1.25

Efficiency & Working Capital

Asset Turnover0.86

Fixed Asset Turnover10.64

Inventory Turnover19.30

Receivables Turnover13.33

Payables Turnover14.20

Days Sales Outstanding27.39

Days Inventory Outstanding18.91

Days Payables Outstanding25.71

Operating Cycle46.3

Cash Conversion Cycle20.59

Working Capital Turnover1.74

Returns & Quality

Return on Equity32.81%

Return on Assets20.83%

Return on Invested Capital-0.92%

ROCE-0.96%

Return on Tangible Assets23.20%

Operating Return on Assets-0.90%

Income Quality0.84

Tax Burden0.96

Interest Burden-27.23

Balance Sheet & Intrinsic Metrics

Enterprise Value$2.25B

Invested Capital$433.09M

Working Capital$335.53M

Tangible Asset Value$371.07M

Net Current Asset Value$321.83M

Graham Number$20.03

Graham Net-Net$5.74

Book Value / Share$8.27

Tangible Book Value / Share$7.21

Cash / Share$7.26

Financial Health Scores

Piotroski Score7

Altman Z-Score14.79

Revenue$458.09M

EBIT$-4.23M

Market Cap$2.6B

Working Capital$335.53M

Retained Earnings$-505.45M

Total Assets$532.99M

Total Liabilities$107.39M